These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14692714)

  • 1. Two schedules of application for mesna and their influence on the thiol-metabolism.
    Kempgens B; Kisro J; Gruber Y; Bahrs H; Wagner T
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):608-9. PubMed ID: 14692714
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study.
    Loeffler TM; Weber FW; Hausamen TU
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S125-8. PubMed ID: 1795000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I; Keefe D; Myers M; Caruso D
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.
    Souid AK; Fahey RC; Aktas MK; Sayin OA; Karjoo S; Newton GL; Sadowitz PD; Dubowy RL; Bernstein ML
    Drug Metab Dispos; 2001 Nov; 29(11):1460-6. PubMed ID: 11602522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration.
    Katz A; Epelman S; Anelli A; Gorender EF; Cruz SM; Oliveira RM; Marques LA
    J Cancer Res Clin Oncol; 1995; 121(2):128-31. PubMed ID: 7883776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
    Goren MP; Epelman S; Bush DA
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):237-40. PubMed ID: 15184993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.
    Souid AK; Fahey RC; Dubowy RL; Newton GL; Bernstein ML
    Cancer Chemother Pharmacol; 1999; 44(6):498-504. PubMed ID: 10550571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
    Pendyala L; Creaven PJ; Schwartz G; Meropol NJ; Bolanowska-Higdon W; Zdanowicz J; Murphy M; Perez R
    Clin Cancer Res; 2000 Apr; 6(4):1314-21. PubMed ID: 10778956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.
    Celik I; Başçil N; Yalçin S; Güllü IH; Kars A; Barişta I; Tekuzman G
    Acta Oncol; 1997; 36(3):348. PubMed ID: 9208911
    [No Abstract]   [Full Text] [Related]  

  • 10. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.
    Dechant KL; Brogden RN; Pilkington T; Faulds D
    Drugs; 1991 Sep; 42(3):428-67. PubMed ID: 1720382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesna: continuous or bolus infusion?
    Willemse PH; de Vries EG
    J Clin Oncol; 1989 Jun; 7(6):817-9. PubMed ID: 2497231
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
    Kurowski V; Wagner T
    Cancer Chemother Pharmacol; 1997; 39(5):431-9. PubMed ID: 9054957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
    Mayer J; Vásová I; Korístek Z; Navrátil M; Klabusay M; Doubek M; Vorlícek J; Cernilová I; Vodvárka P; Petráková K
    Eur J Haematol Suppl; 2001 Jul; 64():21-7. PubMed ID: 11486396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.
    Hall G; Lind MJ; Huang M; Moore A; Gane A; Roberts JT; Cantwell BM
    Postgrad Med J; 1990 Oct; 66(780):860-1. PubMed ID: 2129174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide in soft tissue sarcoma.
    Zaidi SH; Iqbal Z; Mallick JA
    J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272
    [No Abstract]   [Full Text] [Related]  

  • 17. Ifosfamide, mesna and vincristine in paediatric oncology.
    de Kraker J; Voûte PA
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():165-6. PubMed ID: 6414690
    [No Abstract]   [Full Text] [Related]  

  • 18. Undifferentiated sarcoma of the maxillary sinus: report of a rare case in an adult.
    Hosokawa S; Takebayashi S; Mineta H; Suzuki K; Baba S
    Auris Nasus Larynx; 2009 Feb; 36(1):92-5. PubMed ID: 18614305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies.
    Miglietta L; Marenghi C; Nizzo R; Foglia G; Ragni N; Boccardo F
    Oncology; 2001; 60(2):116-22. PubMed ID: 11244325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral mesna: a review.
    Goren MP
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):65-71. PubMed ID: 1485175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.